97227 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
Sub-classes:ANTIBODY-ALK5 INHIBITOR CONJUGATES AND THEIR USES
#2ANTIGEN-BINDING MOLECULE CONTAINING MODIFIED ANTIBODY VARIABLE REGION
#3MONOCLONAL ANTIBODIES TARGETING CONFORMATION-SPECIFIC EPITOPES OF IMMUNOGLOBULIN LIGHT CHAINS OF THE LAMBDA SUBCLASS
#4V.kappa.4-1-IGLC Polypeptide and Use Thereof
#5NON-IMMUNOGENIC SINGLE DOMAIN ANTIBODIES
#6Anti-SIRPa Antibodies and Methods of Use Thereof
#7T CELL RECEPTORS DIRECTED AGAINST JCHAIN AND USES THEREOF
#8Method of Antigen-Binding Protein Production
#9ANTI-MIGIS-alpha ANTIBODIES AND METHODS OF USE THEREOF
#10TRIPLE COMBINATION ANTIBODY THERAPIES
#11CHIMERIC RECEPTORS
#12SIGLEC LIGANDS, CONJUGATES, AND METHODS OF USE THEREOF
#13IgG EPITOPE AND APPLICATIONS THEREOF AS A DRUG TARGET
#14Tetanus prophylaxis
#15HETERODIMERIC PROTEINS
#16Anti-SIRPα antibodies and methods of use thereof
#17MULTISPECIFIC ANTIBODIES
#18Hypoimmunogenic Biotherapeutics
#19ANTIGEN-BINDING MOLECULES, THE ANTIGEN-BINDING ACTIVITY OF WHICH VARIES ACCORDING TO THE CONCENTRATION OF COMPOUNDS, AND LIBRARIES OF SAID MOLECULES
#20MATERIALS AND METHODS FOR IMPROVED SINGLE CHAIN VARIABLE FRAGMENTS
#21ANTIGEN-BINDING MOLECULE CONTAINING MODIFIED ANTIBODY VARIABLE REGION
#22MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF
#23IMMUNOSUPPRESSANTS IN COMBINATION WITH ANTI-IGM AGENTS AND RELATED DOSING
#24ANTIBODY-ALK5 INHIBITOR CONJUGATES AND THEIR USES
#25Triple combination antibody therapies
#26Method of Antigen-Binding Protein Production
#27CHIMERIC IMMUNOGENS AND METHODS FOR MAKING POLYCLONAL ANTIBODIES AGAINST SPECIFIC EPITOPES
#28Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte Expansion
#29Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte Expansion
#30ULTRAMODULAR IGG3-BASED SPACER DOMAIN AND MULTI-FUNCTION SITE FOR IMPLEMENTATION IN CHIMERIC ANTIGEN RECEPTOR DESIGN
#31Anti-SIRPa antibodies and methods of use thereof
#32Single domain antibodies binding to tetanus neurotoxin
#33Mass Spectrometry Calibrator
#34ANTIBODIES AND COMPOSITIONS FOR USE IN DETECTING OR CAPTURING A POLYPEPTIDE IN A SAMPLE, AND METHODS FOR DETECTING OR CAPTURING A POLYPEPTIDE IN A SAMPLE
#35Complementary RNA linked bispecific T-cell engaging antibodies
#36TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#37Multispecific antibodies
#38ENGINEERED IGA ANTIBODIES AND METHODS OF USE
#39Engineered IGA antibodies and methods of use
#40Calibrator, complex, and method for measuring IgA aggregate
#41Immunoablative therapies
#42METHODS AND REAGENT FOR ANALYSING NUCLEIC ACIDS FROM INDIVIDUAL CELLS
#43Immunoassay methods and compositions for detecting infection involving use of test antigens as cross-reactive control antigens
#44Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said molecules
#45Multi-chain chimeric polypeptides and uses thereof
#46HETERODIMERIC PROTEINS
#47Engineered IGA antibodies and methods of use
#48Engineered IgA antibodies and methods of use
#49ANTIGEN-BINDING MOLECULE FOR ELIMINATING AGGREGATED ANTIGENS
#50PACAP antibodies and uses thereof
#51Basehit, a high-throughput assay to identify proteins involved in host-microbe interaction
#52Materials and methods for improved single chain variable fragments
#53MONOCLONAL ANTIBODY AND NON-SPECIFIC REACTION INHIBITOR
#54IgG epitope and applications thereof as a drug target
#55ANTIBODIES, COMPOSITIONS FOR USE IN DETECTING OR CAPTURING A POLYPEPTIDE IN A SAMPLE, AND METHODS FOR DETECTING OR CAPTURING A POLYPEPTIDE IN A SAMPLE
#56Production of a horseradish peroxidase-igg fusion protein
#57Antigen-binding molecule containing modified antibody variable region
#58Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
#59HINGE MODIFIED ANTIBODY FRAGMENTS AND METHODS OF MAKING
#60Method of treatment
#61TARGET FOR B-CELL DISORDERS
#62Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
#63OB-fold used as scaffold for engineering new specific binders
#64Non-Immunogenic Single Domain Antibodies
#65Immunoablative therapies
#66Immunoparticles and methods of generating and using same
#67NONSPECIFIC REACTION INHIBITOR
#68CHIMERIC RECEPTORS, BIOSENSOR HOST CELLS AND METHODS/USES THEREOF
#69Anti-SIRPA antibodies and methods of use thereof
#70Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
#71AFFINITY LIGANDS AND METHODS RELATING THERETO
#72Drug containing carrier into cell for forming immune complex
#73SINGLE-DOMAIN ANTIGEN-BINDING PROTEINS THAT BIND MAMMALIAN IGG
#74Multispecific antibodies
#75Immunoassay methods and compositions for detecting infection involving use of test antigens as cross-reactive control antigens
#76Method for separating cells using immunorosettes and magnetic particles
#77Tandemly repeated antibody-binding protein and its applications
#78Triple combination antibody therapies
#79PACAP antibodies and uses thereof
#80TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#81Hinge modified antibody fragments and methods of making
#82Antigen-Binding Protein Directed Against Epitope in the CH1 Domain of Human IgG Antibodies
#83ANTI-CD19 scFv (FMC63) POLYPEPTIDE AND USES THEREOF
#84Method for the in situ formation of bifunctional immunological complexes
#85Antibodies targeting B-cell receptor complex membrane bound IgM and uses thereof
#86Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
#87Liquid formulation of long acting insulinotropic peptide conjugate
#88TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#89DIAGNOSING AND TREATING IGA NEPHROPATHY
#90ANTI-CD19 scFv (FMC63) POLYPEPTIDE
#91Serum albumin binding proteins containing immunoglobulin single variable domains
#92Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
#93Affinity proteins and uses thereof
#94Enhanced production of immunoglobulins
#95OB-fold used as scaffold for engineering new specific binders
#96Method for detecting protein by using secondary antibody detected epitope tag
#97Affinity ligands and methods relating thereto
#98Methods for the preparation of compounds directed against interleukin-6 receptor (IL-6R)
#99Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said molecules
#100Antibodies targeting B-cell receptor complex membrane bound IGM and uses thereof
#101Anti-human mIgA antibodies capable of lysing mIgA-B lymphocytes and decreasing IgA production
#102ANTIGEN-BINDING MOLECULE CONTAINING MODIFIED ANTIBODY VARIABLE REGION
#103Non-immunogenic single domain antibodies
#104Anti-CD19 scFv (FMC63) polypeptide
#105OB-fold used as scaffold for engineering new specific binders
#106Anti-human IgG1 antibody
#107Secondary antibody detected epitope and preparation of same
#108Single-domain antigen-binding proteins that bind mammalian IgG
#109Immunoparticles and methods of generating and using same
#110α/β-peptide mimics of Z-domain peptides
#111DRUG CONTAINING CARRIER INTO CELL FOR FORMING IMMUNE COMPLEX
#112Methods of using IL-6R antibodies to block or reduce binding of IL-6 to IL-6R
#113Diagnosing and treating IGA nephropathy
#114Anti-drug antibody assay
#115Anti IL-6R polypeptides and compositions thereof
#116Nucleic acids encoding IL-6R-binding polypeptides
#117Diagnostic and therapeutic methods and their application in amyotrophic lateral sclerosis (ALS)
#118Biological materials and uses thereof
#119TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#120Antigen-binding protein directed against epitope in the CH1 domain of human IgG antibodies
#121ANTI-IGA1 ANTIBODY
#122DIAGNOSING AND TREATING IGA NEPHROPATHY
#123Non-cross-reactive anti IgG antibodies
#124Compositions and methods to treat and control tumors
#125Anti-IL-6R polypeptides and pharmaceutical compositions thereof
#126Methods for treating IgE-mediated disorder
#127Biological materials and uses thereof
#128Immunosensors: scFv-linker design for surface immobilization
#129Assays for detecting antibodies specific to therapeutic anti-IgE antibodies and their use in anaphylaxis
#130MONOCLONAL ANTIBODY AND IMMUNOASSAY USING THE SAME
#131Compositions and Methods Relating to STOP-1
#132PROTEIN VARIANTS HAVING MODIFIED IMMUNOGENICITY
#133IMMUNOGLOBULIN PREPARATION FOR THE TREATMENT OF HIV-1 INFECTION
#134Single-domain antigen-binding proteins that bind mammalian IgG
#135Methods for increasing the effectiveness of antibodies and/or FCY receptor-binding active ingredients
#136OB-FOLD USED AS SCAFFOLD FOR ENGINEERING NEW SPECIFIC BINDERS
#137Cell Culture Media for Enhanced Protein Production
#138ANTI-DRUG ANTIBODY ASSAY
#139Modulation of T helper cell-mediated immune responses
#140Clearance of abnormal IGA1 in IGA1 deposition diseases
#141CONTROL CIRCUITRY FOR PROVIDING AN INTERFACE BETWEEN CONNECTABLE TERMINAL AND PERIPHERAL DEVICE CIRCUITRY
#142Method for treating multiple myeloma
#143RAPID GENERATION OF T CELL-INDEPENDENT ANTIBODY RESPONSES TO T CELL-DEPENDENT ANTIGENS
#144IMMUNOCHROMATOGRAPHIC TEST DEVICE
#145ICAM-1 binding antibodies
#146Method for treating multiple myeloma
#147Immunosensors: scFv-linker design for surface immobilization
#148Conjugate and its use as a standard in an immunoassay
#149Detection of a therapeutic antibody in an experimental animal
#150Targer For B-Cell Disorders
#151Multispecific antibodies
#152Compositions and methods relating to STOP-1
#153Method of Producing Pan-Specific Antibodies
#154Combination therapy and antibody panels
#155Combination therapy and antibody panels
#156Method for identifying antigen specific b cells
#157Antibodies against epitopes with homology to self antigens, methods of preparation
#158Compositions and methods to treat and control tumors by loading antigen presenting cells
#159Methods for immunoglobulin purification
#160Regulation of human serine/threonine kinase
#161Methods and compositions for regeneration of aged skeletal muscle tissues
#162Methods for sterilizing preparations of monoclonal immunoglobulins
#163Protein variants having modified immunogenicity
#164Synthetic antibody phage libraries
#165Novel high protein tortillas
#166Compositions and methods for surrogate antibody modulation of an immune response and transport
#167Piezoimmunosensor